ILD
Conditions
Brief summary
The primary endpoint will be the average SpO₂ achieved throughout the entire training period, comparing both groups.
Detailed description
Dyspnea during daily life activities (mMRC scale, dyspnea domain of the CRQ), Dyspnea during exertion before and after the 6-minute walk test (6MWT) (Borg scale), Exercise capacity measured by the 6MWT without oxygen support, Health-Related Quality of Life (HRQoL) assessed using the KBILD and SF36 questionnaires, Full pulmonary function test (spirometry, lung volumes, diffusion, and blood gases), Adverse effects of the program, Adverse events, Program adherence
Interventions
Sponsors
Eligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint will be the average SpO₂ achieved throughout the entire training period, comparing both groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dyspnea during daily life activities (mMRC scale, dyspnea domain of the CRQ), Dyspnea during exertion before and after the 6-minute walk test (6MWT) (Borg scale), Exercise capacity measured by the 6MWT without oxygen support, Health-Related Quality of Life (HRQoL) assessed using the KBILD and SF36 questionnaires, Full pulmonary function test (spirometry, lung volumes, diffusion, and blood gases), Adverse effects of the program, Adverse events, Program adherence | — |
Countries
Spain